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Abstract
The extent of sequence diversity among the genes encoding 10 antigens (Tp1–10) known to
be recognized by CD8+ T lymphocytes from cattle immune to Theileria parva was analysed.
The sequences were derived from parasites in 23 buffalo-derived cell lines, three cattle-derived
isolates and one cloned cell line obtained from a buffalo-derived stabilate. The results revealed
substantial variation among the antigens through sequence diversity. The greatest nucleotide
and amino acid diversity were observed in Tp1, Tp2 and Tp9. Tp5 and Tp7 showed the least
amount of allelic diversity, and Tp5, Tp6 and Tp7 had the lowest levels of protein diversity.
Tp6 was the most conserved protein; only a single non-synonymous substitution was found in
all obtained sequences. The ratio of non-synonymous: synonymous substitutions varied from
0.84 (Tp1) to 0.04 (Tp6). Apart from Tp2 and Tp9, we observed no variation in the other
defined CD8+ T cell epitopes (Tp4, 5, 7 and 8), indicating that epitope variation is not a uni-
versal feature of T. parva antigens. In addition to providing markers that can be used to exam-
ine the diversity in T. parva populations, the results highlight the potential for using conserved
antigens to develop vaccines that provide broad protection against T. parva.
Introduction
Cattle constitute an important source of livelihood for African pastoralists, whether for societal
status, income generation through meat or milk production and sale, or protection against
additional economic hardships (Anderson, 2003; Mwacharo and Drucker, 2005; Ilatsia et al.
2011). The implementation of preventative measures against disease is imperative to maintain
herd health and productivity, including those situations where livestock share grazing habitat
with wild animal populations (Grootenhuis and Olubayo, 1993; Sitt et al. 2015). Vaccination is
one of the most effective methods of disease prevention. The development of new or improved
vaccines is aided by a clear understanding of the molecular interactions between the host and
pathogen, including potential genetic diversity in the parasite antigens that induce protective
immune responses. Antigenic diversity and antigen variation are exploited by pathogens for
immune evasion in diseases such as malaria, trypanosomiasis and Lyme disease (Frank, 2002).
The protozoan parasite Theileria parva (T. parva) is of particular concern for pastoralists in
sub-Saharan Africa. It is an apicomplexan parasite which induces lymphoproliferative disease
in cattle and is transmitted by tick vectors, predominantly Rhipicephalus appendiculatus.
Infections in cattle may be initiated by ticks that have acquired infection from other cattle
or from African buffalo (Syncerus caffer) and these give rise to distinct clinical syndromes,
referred to as East Coast fever (ECF) and Corridor disease (CD), respectively (Neitz et al.
1955; Barnett and Brocklesby, 1966). In both cases, the disease causes severe economic losses
through morbidity and mortality throughout a large part of eastern, southern and central
Africa (Conelly, 1998). A vaccination procedure used to protect cattle from ECF, called the
Infection and Treatment Method (ITM), is successfully employed in parts of Zambia,
Tanzania, Uganda, Malawi and Kenya, but generally only where pasture is grazed predomin-
antly by cattle (Uilenberg et al. 1977; Morzaria et al. 2000). The most commonly used version
of the ITM vaccine, which comprises a mixture of three T. parva isolates and is known as the
Muguga cocktail, has been shown not to protect cattle introduced into an area previously
grazed only by buffalo (Sitt et al. 2015).
Parasite-specific CD8+ T cells, which recognize epitopes presented on the surface of T.
parva-infected lymphoblasts, have been shown to play a key role in mediating protection in
animals immunized by ITM (McKeever et al. 1994). Immunity induced by ITM with one
parasite isolate frequently does not provide complete protection against challenge with
other parasite isolates and lack of protection has been shown to correlate with parasite strain
specificity of the CD8+ T cell responses (Taracha et al. 1995). Ten antigens expressed by the
intra-lymphocytic schizont stage of the parasite, designated Tp1–Tp10, have been described as
targets of CD8+ T cells from immune cattle, and thus far, CD8+ T cell epitope regions have
been defined for eight of these antigens (Gardner et al. 2005; Graham et al. 2006, 2007;
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Pelle et al. 2011; Hemmink et al. 2016). Sequence analyses of the
genes encoding two of these antigens, Tp1 and Tp2, have revealed
extensive sequence diversity, which was particularly pronounced
in buffalo-derived parasites (Pelle et al. 2011). Specific CD8+ T
cell responses to both antigens in ITM-immunized cattle have
been shown to be parasite strain-specific, although the role of
these antigens in immune protection has not been formally
demonstrated (MacHugh et al. 2009; Connelley et al. 2011). A
more limited analysis of the Tp9 gene has also revealed marked
sequence diversity (Hemmink et al. 2016). Diversity in the
genes encoding the remaining T. parva antigens (TpAg) has not
been examined in detail.
In an effort to increase our understanding of the overall anti-
genic diversity in T. parva, we analysed the sequences of genes
encoding 10 TpAg in infected cell lines derived predominantly
from buffalo, which previous studies have indicated harbour
greatest parasite genetic diversity. The results confirmed the
high level of diversity among the Tp1, Tp2 and Tp9 antigens, sug-
gesting that these would be most useful for parasite strain typing.
On the other hand, the much more limited diversity displayed by
the other antigens, especially in their known CTL epitopes, indi-
cates that these would be the more preferable for inclusion in a
subunit vaccine.
Materials and methods
Parasite isolates
The samples used in these studies are listed in Tables 1–3.
Nineteen of the buffalo-derived stabilates collected from several
regions in Kenya have been described previously (Conrad et al.
1987; Grootenhuis et al. 1987; Baldwin et al. 1988; Pelle et al.
2011) (Supplementary Table S2). Sample BD19 from buffalo
5012 was recovered from the ILRI biorepository, although the his-
tory of the buffalo was not found. Samples from three cattle-
derived infected cell lines were also included in the analysis for
comparison – samples CD16 and CD17 have been described pre-
viously (Pelle et al. 2011) and originate from Nyairo, Kenya, while
the third, CD28, is from Ngong, Kenya. Tp9 analysis was con-
ducted on DNA from an additional 12 cell lines from seven
buffalo-derived field stabilates. Polymerase chain reaction (PCR)
amplicons from these DNA samples and from fifteen of the sta-
bilates described above (Table 3) were cloned and sequenced.
DNA extraction
Sixteen buffalo-derived DNA samples have previously been
described (Pelle et al. 2011). DNA from the additional samples
(see Parasite isolates) was extracted using DNeasy Blood and
Tissue Kit (Qiagen, USA). An aliquot of DNA was diluted to
100 ng µL−1 with either AE buffer or RNase/DNase free water
and frozen. The stock DNA was stored at −20 °C.
PCR and sequencing of stabilates
PCR amplicons were generated from genes encoding the 10 previ-
ously described T. parva antigens (TpAg). PCRmaster mixes com-
prised 10 µL 10 × buffer (Applied Biosystems), 10 µL 25 mM
MgCl2, 1 µL 25 mM dNTP, 1 µL 100 pmole µL
−1 forward and
reverse primers, 0.5 µL Ampli-Taq Gold (Applied Biosystems)
and H2O added to a final volume of 30ul, containing between 2.5
and 5 µL of 100 ng µL−1 gDNA. Cycling conditions can be found
in Supplemental Table 1. Tp1 and Tp2 primers have previously
been described (Pelle et al. 2011). TpAg information including
Genebank accession numbers of references and epitope sequences
can be found in Tables 1–4. Primers for Tp3, Tp4, Tp5, Tp6, Tp7,
Tp8, Tp9 and Tp10 can be found in Table 5.
PCR amplicons were purified either by centrifugal precipita-
tion in PEG8000/MgCl2 or Qiagen PCR purification kit
(Qiagen, USA) and samples eluted in Elution Buffer (EB) or
molecular grade water. Purification via Qiagen kit was conducted
according to manufacturer’s protocol. Purification via PEG8000/
MgCl2 centrifugation was conducted as briefly outlined below:
175 µL of EB was added to 25μL of PCR product and mixed thor-
oughly with 100 µL 30% PEG8000/30 mM MgCl2. Mixtures were
immediately centrifuged at 10 000 g for 20 min at room tempera-
ture after which the supernatant was removed and the pellet was
dissolved in 10 µL water. 1 µL was used to confirm recovery on a
gel. Aliquots of PCR purified products were sequenced at the
BecA-ILRI Hub, Nairobi, Kenya. Sanger sequencing was
conducted on the purified PCR products using the GeneAmp®
9700 system (Applied Biosystems). Additional samples
(BD33-BD44,and BD26, Table 3) were processed and sequenced
after cloning into pGEM-T Easy plasmid vector (Promega) and
sequenced as previously described (Pelle et al. 2011). These add-
itional Tp9 sequences have previously been submitted to Genbank
with the accessions numbers JN828553, JN828535, JN828556,
JN828557, JN828558, JN828559, JN828560, JN828561,
JN828562, JN828563, JN828564 and JN828565, and JQ735950.
Sequence analysis
Sequence analysis, alignments and prediction of encoded proteins
were conducted using Geneious version 7.1.4 created by Biomatters
(http://www.geneious.com) for all T. parva antigens, with variant
alignments conducted using Clustal Omega (https://www.ebi.ac.
uk/Tools/msa/clustalo/) or SCSC Biology WorkBench (http://seq-
tool.sdsc.edu/). Additional Tp9 sequences were translated into pro-
tein sequences using EMBOSS-Transeq software (Rice et al. 2000)
and alignments performed using CLUSTALW version 2.0 (Larkin
et al. 2007). TpAg epitope information has been described in detail
elsewhere (Graham et al. 2006, 2008; Akoolo et al. 2008; Nene et al.
2012; Svitek et al. 2014). All sequence lengths described in this
paper are post-editing for removal of both primer sequence and
weak or mixed trace peaks at the sequence ends-this is expected
with Sanger sequencing.
Sanger sequencing results were obtained in both the forward
(sense) and reverse (anti-sense) directions for each sample.
Consensus sequences for each sample were identified through
detailed analysis of both forward and reverse sequence chromato-
grams and individual nucleotide trace signals. Occasionally
sequence in both directions resulted in multiple traces (double
peaks) at a specific nucleotide location. In these cases, the
‘mixed’ nucleotide received the corresponding IUPAC ambiguity
code. These sequences are identified in Tables 1 and 2. No
sequence had more than four ambiguous residues with the excep-
tion of Buffalo 5012, Tp6. Some ambiguous nucleotides were
observed to be non-synonymous.
Where only one sequence from one direction was obtained, all
trace peaks were required to have strong signal intensity before
including the sequence in data analysis. We define these
sequences as partial sequences in the paper and these partial
sequences are noted with an *. Occasionally these partial
sequences yielded novel single nucleotide polymorphism (SNP)
variants due to SNPs. These sequences are indicated in the Tables.
To confirm sequence identity, a GenBank database search
(nucleotide and protein BLAST) of all the consensus nucleotide
and amino acid sequences was conducted (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). Additionally, the sequences were compared
with available GenBank sequences via BLAST to determine if
the sequences were novel or were a 100% match to previously
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published data. Sequences that did not have 100% identity with
published sequences were considered novel. 100% identity with
a sequence from BLAST was only considered if the query coverage
was over 70%. A new gene allele, protein variant or epitope vari-
ant was also confirmed by alignments with previously published
sequences, as described further below. Alignments also allowed
for detection of sequence introns or insertions and deletions
(indels) in the obtained sequences. Where applicable, introns
were removed from the DNA sequences before translation into
protein.
All amplicons were categorized into allele and protein variants
based on the following criteria; (1) the presence of at least one
SNP difference from any published sequence and (2) the presence
of at least one single amino acid difference from any published
sequence. It is recognized that variant categorization could change
if longer sequences are obtained in the future.
Stabilate gene and protein sequence GenBank accession num-
bers can be found in Supplemental Table S2. Some Tp9 sequences
had previously been deposited in GenBank, but had not under-
gone formal analysis in a publication and were included in this
paper.
Results
A total of 23DNA samples from infected cell lines derived frombuf-
falo, three samples from cattle-derived (non-buffalo-associated)
cultured infected cell lines and one cloned cell line obtained from
a buffalo-derived stabilate were analysed. An additional 12 Tp9
Table 1. Allele and protein variants of Tp1–4 observed in the buffalo- and cattle-derived T. parva stabilates
Sample
ID
Stabilate
name
Tp1a Tp2a Tp3 Tp4
Allele
TP03_0849b
Protein
XP_762973
Allele
TP01_0056
Protein
XP_765583
Allele
TP01_0868
Protein
XP_763892
Allele
TP03_0210
Protein
XP_763228
Buffalo-derived T. parva
BD1 Mara 3 16 15 8 8 6c 4 2 1
BD2 Mara 4 1 1 9 9 10 9 – –
BD3 Mara 18 17 16 10 10 7 6 3 4
BD4 Mara 30 1 1 11 11 6 4 3 4
BD5 Mara 32 1 1 12 12 6 4 9 5
BD6 Mara 42 18 17 13 13 8 9 8 6
BD7 Mara 6998 1 1 14 14 3 8 12 3
BD8 Mara 6999 19 18 7 7 2 5 5 1
BD9 Mara 7001 20 14 15 15 4 2 3 4
BD10 Mara 7546 21 19 16 16 11 9 5 1
BD14 Buffalo 7014 1 1 20 1 5 3 – –
BD15 Buffalo 7698 14 12 21 20 10 9 13 3
BD16 Buffalo 7344 24 21 7 7 5 3 3 4
BD17 Mara 41 – – – – 5* 3* 11d 1
BD18 Buffalo 4740 1 1 44 43 1* 1* 13 3
BD19 Buffalo 5012 1 1 1 1 13*e 9* 1 1
BD20 Buffalo 5489 36 13 48 47 10* 9* 13 3
BD21 Buffalo 6666 40 36 48 47 3* 8* 2 1
BD22 Buffalo 6807 13 11 – – – – 4.1f 1.1
BD23 Buffalo 6818 13 11 – – 10* 9* 4 1
BD24 Buffalo 6819 37 35 45 42 10* 9* 10 1
BD25 6998 cl. 11 38 37 49 45 3 8 12 3
BD26 Buffalo 7065 – – – – – – 9.1 5
Cattle-derived T. parva
CD16 Tc867 BT 106 1 1 1 1 1 1 1 1
CD17 Tc841 IL 57 2 2 47 46 9 7 7 3
CD28 Tc120F344 39 17 46 44 12 9 6 2
aWe have previously published (Pelle et al. 2011) the Tp1 and Tp2 results for samples BD1-BD16. They are included here in italics for completeness.
bThe letters-numbers in this row indicate the reference sequence in the NCBI Genbank.
cNewly identified alleles and protein variants are in boldface.
dAlthough we were unable to determine if the sequence is novel due to four unknown (mixed) nucleotides, the sequence is considered novel due to unique nucleotides in other sequence
regions.
eUnique, validated alleles or protein variants obtained from partial sequences which are their own variant.
fA variant with 0.1 after the variant number indicates a sequence which is identical to the parent variant but has 1–4 unresolved nucleotides which prevents its being regarded as completely
identical to the parent allele (e.g. 4 if labelled 4.1, as in BD22, Tp4).
*partial sequence as defined by only having either the forward or reverse sequence of the allele available for analysis (ie: no complete consensus sequence).
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Table 2. Allele and protein variants of Tp5–8 and Tp10 observed in the buffalo- and cattle- derived T. parva stabilates
Sample
ID Stabilate name
Tp5 Tp6 Tp7 Tp8 Tp10
Allele
TP02_0767a
Protein
XP_765334
Allele
TP01_0188
Protein
XP_765715
Allele
TP02_0244
Protein
XP_764810
Allele
TP02_0140
Protein
XP_764709
Allele
TP04_0772
Protein
XP_764408
Buffalo-derived T. parva
BD1 Mara 3 3b 1 13 1 7 2 12 7 11 1
BD2 Mara 4 1 1 3 2 8.1, 2.1c 2d – – – –
BD3 Mara 18 1 1 6 1 3 2 – – 10 1
BD4 Mara 30 2*e 1* 7 1 2 2 2 4 10.1 1
BD5 Mara 32 1* 1* 8 1 7 2 12 7 6 5
BD6 Mara 42 1 1 13.1 1.1 2 2 11 7 1 1
BD7 Mara 6998 4 2 1 1 8 2 6 6 12 5
BD8 Mara 6999 1 1 2 1 7 2 5 6 7 2
BD9 Mara 7001 1 1 4 1 7 2 – – 10 1
BD10 Mara 7546 1 1 5 1 7 2 – – 11 1
BD14 Buffalo 7014 1 1 9 1 8 2 11 7 13*e 1.1, 4.1, 5.1, 6.1*f
BD15 Buffalo 7698 3 1 12 1 8* 2* 4 5 3 4
BD16 Buffalo 7344 – – 11 1 8 2 6 6 – –
BD17 Mara 41 – – – – 5.1 2d 2 4 10 1
BD18 Buffalo 4740 – – 12.1g 1 2 2 3 3 10 1
BD19 Buffalo 5012 1* 1* 9.1 1 1 1 1 1 1 1
BD20 Buffalo 5489 – – 13 1 7 2 7 2 6 1.1, 4.1, 5.1, 6.1f
BD21 Buffalo 6666 – – 13 1 7 2 9 7 5*e 1.1, 4.1, 5.1, 6.1*f
BD22 Buffalo 6807 1* 1* – – 5 2 10.1, 11.1 6.1, 7.1 9*e 1.1, 4.1, 5.1, 6.1*f
BD23 Buffalo 6818 6*e 1* 13 1 8.1 2 10 7 – –
BD24 Buffalo 6819 5*e 3*e 10 1 9.1g 3d 11 7 8 3
BD25 6998 cl. 11 – – 11 1 8 2 6 6 11 1
BD26 Buffalo 7065 – – 13* 1* 6 2 11 7 – –
Cattle-derived T. parva
CD16 Tc867 BT 106 – – 1 1 – – 1 1 1 1
CD17 Tc841 IL 57 – – 1 1 1* 1* 1 1 2 6
CD28 Tc120 F344 – – – – 4*e 1* 8 7 4 1.1, 4.1, 5.1, 6.1f
aThe letters-numbers in this row indicate the reference sequence in the NCBI Genbank.
bNewly identified alleles and protein variants are in boldface.
cA variant with 0.1 after the variant number indicates a sequence which is identical to the parent variant but has 1–4 unresolved nucleotides which prevents its being regarded as completely identical to the parent allele (e.g. 8 if labelled 8.1, as in BD2, Tp7).
dAlthough the nucleotide sequence had unknown (mixed) nucleotides (i.e. S = C or G, R = A or G, Y = C or T), upon translation, these nucleotides resulted in synonymous protein sequence.
eUnique, validated alleles or protein variants obtained from partial sequences which are their own variant.
fThese sequences were shorter than the rest and could have been any of the variants noted in the table above as these sequence areas were an identical overlap with variants 1, 4, 5 and 6.
gAlthough we were unable to determine if the sequence is novel due to unknown (mixed) nucleotides, the sequence is considered novel due to unique nucleotides in other sequence regions.
*Partial sequence as defined by only having either the forward or reverse sequence of the allele available for analysis, if also labelled with *.
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Table 3. Allele and protein variants of Tp9 observed in the buffalo- and cattle-derived theileria stabilates
Sample ID Stabilate name
Genomic DNAa Cloned DNAa
Allele
TP02_0895b
Protein
XP_765463b Epitope Allele Protein Epitope
Buffalo-derived T. parva
BD1 Mara 3 4 22 AKFPGMKKG 2 4 NKFKSMGIG
BD2 Mara 4 – – – 3 5 AKFPGMKKG
BD3 Mara 18 13c 15 EKFQRMGIG 7 19 AKFPGMKKG
BD4 Mara 30 15 24 EKFQRMGIG 13 15 EKFQRMGIG
BD5 Mara 32 – – – 2 4 NKFKSMGIG
BD6 Mara 42 4 22 AKFPGMKKG 10 16 EKFQRMGIG
BD7 6998 18 6 EKFQRMGIG 3 5 AKFPGMKKG
BD8 6999 – – – 17 18 EKFQRMGIG
BD9 7001 – – – 14 23 EKFQRMGIG
BD10 7546 – – – 16 27 EKFKHMGIG
BD14 7014 – – – 12 2 NKFKSMGIG
BD15 7698 – – – 2 4 NKFKSMGIG
BD16 7344 6 17 AKFPNLKAR 9 8 EKFKRMGMK
BD17 Mara 41 – – – – – –
BD18 4740 11 3 NKFKSMGIG – – –
BD19 5012 1 1 AKFPGMKKS – – –
BD20 5489 – – – – – –
BD21 6666 – – – – – –
BD22 6807 – – – – – –
BD23 6818 – – – – – –
BD24 6819 – – – – – –
BD25 6998 cl. 11 6 17 AKFPNLKAR
BD26 7065 – – – – – –
BD27 7014, st.3506a – – – 4 22 AKFPGMKKG
BD28 7014, st.3570a – – – 1 1 AKFPGMKKS
BD29 7014, st.3081a – – – 26 7 EKFKHMRIG
BD30 7014, st.3081a – – – 25 11 EKFKRMGMK
BD31 7014, st. 3081a – – – 24 12 EKFKRMGMK
BD32 7014, st.3081a – – – 21 26 NKFPGMKKG
BD33 7014, st.3081a – – – 23 25 AKFPGMKKG
BD34 7014, st. 3081a – – – 19 9 NKFKHMRIG
BD35 7752, st. 4110a – – – 27 13 EKFKHMGIG
BD36 7344, st. 3591a – – – 28 14 EKFKHMGIG
BD37 7065, st. 3120a – – – 20 21 EKFQRMGIG
BD38 6999, st. 3123a – – – 22 20 AKFPGMKKG
BD39 6998, cl.19a – – – 18 6 EKFQRMGIG
Cattle-derived T. parva
CD16 Tc 867 Bt106 1 1 AKFPGMKKS – – –
CD17 Tc 841 IL57 – – – 8 – EKFQRMGIG
CD28 Tc 120 F344 – – – 5 10 RKFQRMGIG
aGenomic DNA sequences were obtained directly from purified DNA; cloned DNA sequences were obtained from plasmids into which genomic DNA had been cloned.
bReference sequence accession number.
cNewly identified alleles, protein variants and epitopes are in boldface.
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sequences (from cell lines derived from buffalo) were analysed.
Detailed information including primer sequence, length of PCR
amplicons, edited sequence length, number of SNPs, nucleotide
and protein variants have been summarized for all Tp genes in
Table 5; limited information of these specific parameters is given
in the text. Amplicons were not generated for each gene from
every sample and not all amplicons generated readable sequences
(Tables 1–3). The Tp1 and Tp2 sequences from 16 of the cell
lines mentioned in this study have been published previously
(Pelle et al. 2011) and are included for completeness.
Sequence analysis
The nucleotide and amino acid sequences are available as sequence
alignments in Supplementary Tables S3–S12. GenBank accession
numbers for these sequences are given in Supplementary
Table 2. A summary of the findings for the data below can be
found in Tables 1–5, and 6. Table 6 also shows the percentage of
the full-length gene represented by the amplicon for each gene.
Nucleotide variant diversity
As shown in Tables 1–3, between 5 and 12 novel variants were
identified in all the antigens analysed. To compare the nucleotide
diversity among the antigen genes, a nucleotide diversity ratio was
determined for each gene by calculating the ratio of the number of
nucleotide variants to the total number of sequences obtained for
that gene (Table 6). Tp7 and Tp5 had the least allele diversity,
with diversity ratios of 0.36 and 0.38, respectively, whereas Tp1,
Tp2 and Tp9 had the highest allele diversity ratios, ranging
from 0.73 to 0.78. Tp3, Tp4, Tp6, Tp8 and Tp10 were moderately
diverse with ratios between 0.54 and 0.57.
We also examined the allele sequences for the presence of
novel indels or introns. Only one novel Tp3 allele, v9, had the
in-frame trinucleotide insertion AAA (amino acid K) found in
the reference sequence and there are numerous indels throughout
the Tp9 gene.
Interestingly, sequencing of the cloned Tp9 PCR products
revealed six different sequences from one buffalo (BD27-BD34),
suggesting that the buffalo was either infected concurrently or
in succession with several strains of T. parva.
Protein variant diversity
Between one and eight novel protein variants were identified in
antigens analysed. As for the nucleotide diversity, we assessed the
protein variant diversity by calculating the ratio of the number of
protein variants to the number of sequences obtained for each
antigen (Table 6). Tp1, Tp2 and Tp9 were again the most diverse
with ratios between 0.73 and 0.78. On the other hand, Tp6 was by
far the most conserved protein (ratio of 0.09) reflecting the fact
that only one sample (BD2) expressed a Tp6 antigen which varied
from the reference sequence. The remaining antigens showedmod-
erate diversity ratios, which were all lower than the corresponding
nucleotide diversity ratios. A more direct measure of this is the
ratio of the number of protein variants to the number of nucleotide
variants per antigen. For Tp1, Tp2 and Tp9, the ratios were 1, 1 and
0.96, as, with one exception for Tp9, every allelic variant encodes a
unique protein. On the other hand, Tp6 showed a low ratio of
protein to nucleotide variants of 0.15, with the remaining antigens
revealing moderate ratios of 0.46–0.69. In addition to these
observations, it was noted that the most common protein variant
of Tp3 (v9) was found in nine of the 24 samples sequenced, while
each of the five new Tp4 protein variants differed by only a single
amino acid from the reference sequence.
Synonymous vs non-synonymous substitutions
As another direct comparison of diversity among the genes, we
determined the total number of SNP locations and the ratio of
the number of non-synonymous to synonymous SNP locations
for all antigens except Tp9. Tp9 had extensive diversity for
which there is a large number of SNP locations and indels distrib-
uted throughout the gene. The Tp2 gene had by far the greatest
number of SNP locations (220 or 46% of the predicted amplicon
length) compared with the other genes which ranged from 19 to
36 SNP locations. Tp1 showed the lowest conservation of protein
sequences with a ratio of 0.84, compared with Tp4, Tp5, Tp7 and
especially Tp6, all of which showed ratios of less than 0.20.
Remarkably, Tp6 differed at only one amino acid residue in the
single protein sequence which differed from the reference
sequence. We also noted that, among the Tp5 sequences, those
from BD7 and BD24 expressed the majority of SNPs and shared
a high degree of similarity, while the other novel Tp5 alleles dif-
fered from the reference sequence at 1, 2 or 3 residues only.
Diversity in epitope sequences
CTL epitopes have not yet been defined for two (Tp3 and Tp6) of
the 10 antigens included in this study while the recently reported
epitope for Tp10 (Hemmink et al. 2016) lies outside the region
sequenced in this paper. Remarkably, no epitope diversity was
observed in Tp4, Tp5, Tp7, or Tp8. On the other hand, new epi-
tope sequences were found at all six Tp2 epitope locations, with
one sample (CD28) expressing new variants at all six locations
(Table 4). Between 5 and 7, epitope variants were observed at
Table 4. Tp 2 epitopes observed in the buffalo- and cattle-derived theileria stabilates
Sample ID Epitope 1 Epitope 2 Epitope 3 Epitope 4 Epitope 5 Epitope 6
BD18 TNEELKKLGMV (V16) EGLDMEALF (V12) KTSKGMTKVGR (V15) FGQSIKCVA (V8) QSIKCVAQH (V7) KGDVPNPCDW (V10)
BD19 SHEELKKLGML (V1) DGFDRDALF (V1) KSSHGMGKVGK (V1) FAQSLVCVL (V1) QSLVCVLMK (V1) KTSIPNPCKW (V1)
BD20, 21 SDNELDTLGLL (V4) PDLDKNRLF (V2) LTSHGMGKIGR (V3) LAASIKCVS (V3) ASIKCVSQH (V20)a KPSIPNPCDW (V19)
BD24 SDSELETLGML (V26)a PDPDKQRLF (V8) LTSKAMSTVGK (V11) FAQSIYCVA (V21) QSIYCVANN (V10) KGDVPNPCQW (V8)
BD25 SDDELRKLGML (V15) DGFDRDALF (V1) KSSHGMGKVGR (V14) FVESIMCVI (V14) ESIMCVIKK (V14) KEDVPNPCDW (V3)
CD16 SHEELKKLGML (V1) DGFDRDALF (V1) KSSHGMGKVGK (V1) FAQSLVCVL (V1) QSLVCVLMK (V1) KTSIPNPCKW (V1)
CD17 SDNELDTLGLL (V4) PDLDKNRLF (V2) LTSHGMGKIAR (V25) LAASIKCVS (V3) ASIKCVSHH (V3) KPSVPNPCDW (V2)
CD28 TEEELKKMGMV (V27) EGFDKEKLF (V22) KSSKSMGIVGR (V24) FVQSIMCVI (V20) QSIMCVINK (V21) VNDIPNPCKW (20)
aNewly identified epitope sequences are in boldface.
Epitope variant number is found in (). Original epitope variant numbers are defined in Pelle et al. 2011. Epitope variant numbers are separate from protein variant numbers.
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Table 5. Comparative sequence information on TpAg1–10 observed in the buffalo- and cattle-derived theileria stabilates
Antigen
Primers 5’ – 3’
Forward
Reverse
Predicted length
of amplicona
(%)
Lengths of
readable
sequence
Total no.
sequences
obtained
Total no.
SNP
locationsb
Total no.
allelesc,d
Total no.
non-synonymous
SNP locations
Total no.
protein
variantsc,d
Total no.
epitope
variants
Tp1 ATGGCCACTTCAATTGCATTTGCC
GAAGCTCATAAATATTTCATT
387 (22) 363–399 11 19 8 16 8 2
Tp2 ATGAAATTGGCCGCCAGATTA
GAAGCCTCCGGCACTTCATAG
483 (47) 456–480 9 220 7 92 7 See Table 2
Tp3 ATGAAATTAAATACTATCGCAATAG
ACCTTCACTAAGAGTCCAGACGATAAT
735 (89) 686–726 24 26 13 12 9 n/a
Tp4 CCAATTGGTGATTTAGCAACA
CTCCGTAAATCATGTTAATGGAGT
692 (27) 386–422 24 36 13 5 6 1
Tp5 ATGAGGAAGCGAGTTTGGG
CGATATCGATGATTTATAA
238 (31) 200–238 16 26 6 3 3 1
Tp6 ATGGCTCAGATTCCTGTTG
CTCTTACTCTCAACTGATAAATAA
1005 (92) 569–833 23 23 13 1 2 n/a
Tp7 ATGGAGGCACTGCAAGCAGGC
GTCACTGACGAGGAGGAGAAAAAG
417 (14) 299–332 25 33 9 4 3 1
Tp8 ATGCTTGGAAATCATGTCATGGGA
CTCCTTCGCAGTGTACGCAGTTTAA
1275 (81) 931–1109 22 19 12 6 7 1
Tp9 ATGAATGTTCTAACTACTGG
CGTAATAAACCATGGACAAAACAATAA
958 (95) 326–1057 37 >100 28 >100 27 12
Tp10 GACTACGCTCTTCTTACCAC
CCATCCAGGAGTGTAATGCC
916 (89) 505–824 22 24 13 7 6 n/a
aThe sequence length of the predicted amplicon from the reference sequence, excluding primers, is shown. The figures in brackets represent the length of the amplicon as a percentage of the length of the coding sequence from the reference gene, including introns.
bSNPs within introns are not included.
cAlleles or protein variants which have ambiguous residues (labelled X.1 in Table 1) are not included, unless they are unique, validated variants.
dUnique, validated alleles or protein variants obtained from partial sequences are included if the constitute a variant.
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each of the six epitope regions for the nine sequenced samples.
For Tp9, of the 37 samples which were successfully sequenced,
there were 11 variants of the single defined epitope and these
were represented between 1 and 10 times within the sequences.
In all, the results indicate that the substantial epitope variation
previously observed in Tp2 and Tp9 is not a universal feature of T.
parva CTL antigens.
Discussion
The studies reported in this paper were undertaken to evaluate the
extent of diversity among genes encoding T. parva CD8+ T cell
antigens from buffalo-derived parasites. Sequence diversity is a
prominent feature of the two previously studied T. parva antigens,
Tp1 and Tp2, particularly in buffalo-derived T. parva (Pelle et al.
2011). Antigenic diversity, or lack thereof, can be important in
parasite immune evasion, and, for T. parva, previous studies
have implicated epitope sequence variation in evasion from the
CTL response (MacHugh et al. 2009; Connelley et al. 2011). Of
practical significance, widespread sequence diversity among func-
tional CD8+ T cell antigens would greatly increase the challenge
of designing a broadly protective subunit vaccine against the para-
site. The overall conclusion derived from the data reported here is
that, although there was substantial diversity at the nucleotide
level, extensive diversity in the amino acid sequences is not a fea-
ture of all antigens. In particular, no polymorphism was observed
in the CD8+ T cell epitope sequences in four antigens (Tp4, 5, 7
and 8) for which the epitopes have been defined, compared with
the marked variation in epitope sequences observed in Tp2 and
Tp9 and to a lesser extent in Tp1.
There was a considerable difference in the degree of diversity
observed in the antigen sequences, as summarized in Tables 5
and 6. The findings on diversity were relatively consistent based
on ratios obtained for the following parameters: (1) the number
of nucleotide variants/number of sequences obtained, (2) the
number of protein variants/number of sequences obtained, (3)
the number of protein variants/number of nucleotide variants,
and (4) the number of non-synonymous SNP locations/total
number of SNP locations. Tp1, Tp2 and Tp9 were consistently
the most diverse (the highest ratios) whereas Tp4, Tp5, Tp6
and Tp7 were consistently the least diverse (the lowest ratios).
No diversity was observed in the epitope sequences of the Tp4,
Tp5, Tp7 and Tp8 antigens, suggesting that extensive diversity
is not a universal feature of T. parva CTL antigens. However,
the data need to be interpreted with some caution, given that
the sequences which were analysed represent different propor-
tions of the coding region of each gene. We also detected very
few novel indels and introns, suggesting that the major diversity
among the antigen genes is due to SNPs and not variations in
the indel or intron composition.
In comparing the different antigen genes, Tp1, Tp2 and Tp9
were the most challenging to sequence, sometimes resulting in
failure to obtain a PCR product or in sequences that were obvi-
ously mixed. In contrast, sequences obtained from Tp6, Tp7
and Tp8 usually resulted in good quality sequences. A likely
explanation for the former inconsistency is that these genes pos-
sess sequence diversity in the region corresponding to one or both
primers. Although the primers used were initially shown to gen-
erate products from a panel of laboratory isolates of T. parva, it is
possible that some allelic variants are not amplified. As further
genome sequence data becomes available for more T. parva iso-
lates, it may be possible to develop improved PCR primers.
However, at least for Tp2 and Tp9, this may still be challenging
in view of the extensive nucleotide differences throughout these
genes. The ambiguous mixed sequences are almost certainly due
to infection of the cell lines with two or more strains of the para-
site, resulting in several sequences in the PCR amplicon.
It has been known for some time that cells infected with the
closely related theilerial parasite, T. sp. buffalo, can be established
in vitro from infected buffalo (Zweygarth et al. 2009). Recent
research published after the current study has also shown that
this parasite can infect cattle and that cell lines established from
buffalo or cattle co-grazed with buffalo may be co-infected with
T. parva and T. sp. buffalo (Bishop et al. 2015). To avoid the pos-
sibility of obtaining sequences from both Theileria species, we
used species-specific primers to screen for the presence or absence
of T. parva and T. sp. buffalo (Bishop et al. 2015) and only used
cell lines that did not have a detectable infection with T.sp. buffalo
It should be noted that the sequences obtained may not be
strictly representative of the parasite populations in vivo, as the
approach of direct sequencing of PCR amplicons may generate
a bias, in the case of infections with mixed genotypes, to strains
that are more abundant or whose sequences are more efficiently
amplified by the PCR primers employed. Additionally, mainten-
ance of Theileria-infected cells in culture may select for
parasite-infected cells which are more suited to in vitro cell propa-
gation, thus altering the composition of the parasites originally
present in the host. Hemmink et al. (2016) have previously
shown that 454 deep sequencing (Roche) can be used to reveal
alleles present at a low frequency in the parasites in the
Table 6. Diversity within the individual antigens
TpAg
No. nucleotide variants/No.
sequences obtained
No. protein variants/No. of
sequences obtained.
No. protein variants/No.
nucleotide variants
No. non-synonymous SNP locations/
Total No. SNP locations
Tp1 8/11 (0.73) 8/11 (0.73) 8/8 (1) 16/19 (0.84)
Tp2 7/9 (0.78) 7/9 (0.78) 7/7 (1) 92/220 (0.42)
Tp3 13/24 (0.54) 9/24 (0.38) 9/13 (0.69) 12/26 (0.46)
Tp4 13/24 (0.54) 6/24 (0.25) 6/13 (0.46) 5/36 (0.14)
Tp5 6/16 (0.38) 3/16 (0.19) 3/6 (0.5) 3/26 (0.12)
Tp6 13/23 (0.57) 2/23 (0.09) 2/13 (0.15) 1/23 (0.04)
Tp7 9/25 (0.36) 5/25 (0.20) 3/9 (0.33) 4/33 (0.12)
Tp8 12/22 (0.55) 7/22 (0.32) 7/12 (0.58) 6/19 (0.32)
Tp9 28/37 (0.76) 27/37 (0.73) 27/28 (0.96) NAa
Tp10 13/22 (0.59) 6/22 (0.27) 6/13 (0.46) 7/24 (0.29)
aDue to extensive gene diversity, it was not feasible to conduct this analysis.
Numbers in bold indicate the top three most diverse TpAg per group.
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Muguga cocktail ITM vaccine. In a parallel study, we have applied
the same high-throughput sequencing approach to compare the
sequences of six of TpAg genes (Tp1, Tp2, Tp4, Tp5, Tp6 and
Tp10) examined in the current study, in samples obtained from
naturally infected buffalo in two geographically distant locations;
PCR amplicons of segments of these genes generated from DNA
extracted directly from buffalo blood were used for sequencing.
These studies generated larger sets of sequences and consequently
revealed greater diversity but overall the observed patterns of
diversity were very similar to those observed here, ranging from
some highly polymorphic genes showing high ratios of non-
synonymous:synonymous nucleotide substitution to others show-
ing lower diversity and low ratios of non-synonymous:synonym-
ous nucleotide substitution, with relatively conserved amino
acid sequences (Hemmink et al. 2017).
Our studies have identified major variation in the level of
sequence diversity exhibited by the genes encoding different
T. parva antigens recognized by parasite-specific CD8+ T cells. The
extensive polymorphism seen in some antigens could be of great
value for typing and differentiating populations of T. parva.
Conversely, limited diversity is a most desirable feature of antigens
that could potentially be used in a subunit vaccine against disease
caused by T. parva. The epitopes recognized by CD8+ T cells from
T. parva-immune cattle depend heavily on the class I MHC back-
ground of the individual animal. This adds to the complexity of the
developmentof subunit vaccines andmaywell require the use ofmul-
tiple antigens to consistently generate the desired immune responses.
We and others have observed that the currently used Muguga
cocktail live vaccine offers limited protection to cattle introduced
into pasture co-grazed predominantly by buffalo (Bishop et al.
2015; Sitt et al. 2015). Early studies (Radley et al. 1979; Young,
1981) providing an indication that this is associated with greater
antigenic diversity among buffalo-derived parasites have been
supported by a subsequent study that showedmuchmore extensive
diversity in the amino acid sequences of the Tp1 and Tp2 CD8+
T cell antigens in buffalo isolates compared from those derived
from cattle (Pelle et al. 2011). However, the studies reported here
suggest that antigenic diversity is not a universal feature of the
T. parva antigens identified to date, but rather that immune cattle
can also respond to antigens that appear to be highly conserved
among T. parva isolates, including those from cattle.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0031182018000264
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